Filter Results:
(1,141)
Show Results For
- All HBS Web
(1,141)
- People (1)
- News (315)
- Research (706)
- Events (5)
- Multimedia (14)
- Faculty Publications (418)
Show Results For
- All HBS Web
(1,141)
- People (1)
- News (315)
- Research (706)
- Events (5)
- Multimedia (14)
- Faculty Publications (418)
- June 2016
- Teaching Plan
Terrapin Laboratory
By: Joseph B. Fuller and Andrew Otazo
This teaching plan accompanies the case "Terrapin Laboratory," HBS No. 315-098. That case describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug... View Details
- 01 Oct 2001
- News
Christopher Cox: Capitol Hill Intellectual
U.S. Court of Appeals; made partner at Latham & Watkins, where he specialized in corporate finance; founded (with his father) a company that published an English version of the Russian newspaper Pravda; was appointed senior associate... View Details
- 01 Dec 2010
- News
Chaotic Funding Derails Research
time to consider the devastating implications of this chaotic funding environment. And to do that, one needs to understand how a modern research lab operates. A typical lab has twenty to forty people, led by a senior researcher (the... View Details
- 21 Nov 2024
- Blog Post
Thoughts on the JD/MBA From a Recent Grad
Criminal Division, Fraud Section; and her third summer at Covington & Burling LLP, a law firm. After graduating, Anne clerked for Judge Harry T. Edwards of the U.S. Court of Appeals for the District of... View Details
- 20 Dec 2011
- First Look
First Look: December 20
http://www.hbs.edu/research/pdf/12-041.pdf What Makes the Bonding Stick? A Natural Experiment Involving the Supreme Court and Cross-Listed Firms Authors:Amir N. Licht, Christopher Poliquin, Jordan I. Siegel,... View Details
Keywords: Carmen Nobel
- 11 Mar 2001
- Research & Ideas
Group Therapy
undertake coordinated action despite the fact that they are often composed of very diverse units; and the role families play in these organizations. Court systems, contract law, stock markets, accounting... View Details
Keywords: by Peter Jacobs
- 01 Apr 2014
- First Look
First Look: April 1
opportunity for success; and (4) perhaps most damning, the original evidence that the courts relied upon to conclude that Section 203 gave bidders a meaningful opportunity for success was seriously flawed-so... View Details
Keywords: Sean Silverthorne
- March 2015 (Revised September 2016)
- Case
Terrapin Laboratory
By: Richard G. Hamermesh and Joseph B. Fuller
Describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. The associated teaching materials provide students the opportunity... View Details
Keywords: Business Growth; Entrepreneurial Management; Entrepreneurship; Growth Strategy; Market Entry; Venture Capital; Growth Management; Expansion; Financing and Loans; Health Care and Treatment; Health Testing and Trials; Business Startups; Pharmaceutical Industry; Health Industry
Hamermesh, Richard G., and Joseph B. Fuller. "Terrapin Laboratory." Harvard Business School Case 315-098, March 2015. (Revised September 2016.)
- 01 Feb 2011
- First Look
First Look: Feb. 1
Bonding Stick? A Natural Experiment Involving the Supreme Court and Cross-Listed Firms Authors:Amir N. Licht, Xi Li, and Jordan I. Siegel Abstract Using a natural experiment to... View Details
- 18 Jul 2018
- Research & Ideas
No More General Tso's? A Threat to 'Knowledge Recombination'
Cohly was skilled in Ayurveda, the ancient Indian practice of herbal medicine, and suggested they try using turmeric to heal the wound instead. The spice worked, and Das and... View Details
- 15 Dec 2024
- News
After Ozempic
Alzheimer’s disease in a phase 2 trial. Other trials are examining the extent to which GLP-1s can curb cravings for alcohol, nicotine, opioids, and even psychostimulants—or whether it could help eliminate... View Details
- 08 May 2012
- First Look
First Look: May 8
case updates events since the court's ruling against Myriad Genetics on March 29, 2010, and should be used in conjunction with "Gene Patents (A)." On July 29, 2011, a U.S. appeals court reversed... View Details
Keywords: Carmen Nobel
- 15 Jun 2004
- Conference Presentation
What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study
By: William B. Simpson, Frances J. Hayes, Andre B. Araujo and John B. McKinlay
Keywords: Measurement and Metrics; Health Testing and Trials; Age Characteristics; Gender Characteristics; Massachusetts
Simpson, William B., Frances J. Hayes, Andre B. Araujo, and John B. McKinlay. "What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study." Paper presented at the Enocrine Society Annual Meeting, New Orleans, LA, June 15, 2004.
- 03 Apr 2007
- First Look
First Look: April 3, 2007
Whether this would be enough to stop the trend was a matter of much debate. Meanwhile, the industry continued to consolidate. In 2004, Sony Music and BMG, the third- and fifth-largest record firms at the... View Details
Keywords: Martha Lagace
- 10 May 2016
- First Look
May 10, 2016
Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein, and Kevin Volpp Abstract—Purpose: We tested the effects of employer subsidies on employee enrollment, attendance, and weight loss in a... View Details
Keywords: Carmen Nobel
- Fast Answer
Pharmaceuticals: Pipeline
service of the U.S. National Institutes of Health. Contains trials sponsored by the NIH, other federal agencies, and private industry. Studies listed in the database are conducted in 50 states View Details
- 14 May 2007
- Research & Ideas
The Key to Managing Stars? Think Team
What contributes to an individual's ability to remain a star? To what extent does past star performance predicate future star performance? And to what extent does a key organizational factor—colleague quality—help or hinder the ability to... View Details
Keywords: by Martha Lagace
- June 2004 (Revised November 2004)
- Case
Acorda Therapeutics: Rebuilding the Spinal Cord
Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic... View Details
Keywords: Decision Making; Science-Based Business; Health Testing and Trials; Business Startups; Product Development; Biotechnology Industry
Enriquez-Cabot, Juan, Jonathan West, Marina Kolesnik, and Fiona Murray. "Acorda Therapeutics: Rebuilding the Spinal Cord." Harvard Business School Case 604-014, June 2004. (Revised November 2004.)
- 10 Oct 2007
- First Look
First Look: First Look: October 10
numbered. What the industry must embrace in its place is a business model based on a larger portfolio of targeted—and therefore more effective and profitable—treatments, not a limited palette of one-size-fits-all drugs. The current... View Details
Keywords: Martha Lagace
- 02 Aug 2024
- HBS Case
How a Mission to Cut Food Waste Launched a Multimillion-Dollar Venture
On a hectic Friday in October 2016, Josh Domingues wondered if he had made a mistake quitting the security of a well-paying job managing contracts for professional hockey players to start a new venture selling nearly expired groceries at discount prices. After all, a... View Details